Holen Sie sich die Stockscreener-App
17.54
8.94%
1.44
Schlusskurs vom Vortag:
$16.10
Offen:
$16.28
24-Stunden-Volumen:
2.46M
Relative Volume:
2.60
Marktkapitalisierung:
$976.63M
Einnahmen:
$312.78M
Nettoeinkommen (Verlust:
$-143.56M
KGV:
-6.5204
EPS:
-2.69
Netto-Cashflow:
$1.22M
1W Leistung:
+14.19%
1M Leistung:
-3.73%
6M Leistung:
-17.15%
1J Leistung:
+18.67%
1-Tages-Spanne:
$16.28
$17.82
1-Wochen-Bereich:
$15.48
$17.82
52-Wochen-Spanne:
$12.90
$34.84
Caredx Inc Stock (CDNA) Company Profile
Firmenname
Caredx Inc
Sektor
Branche
Telefon
415-287-2300
Adresse
8000 MARINA BLVD, BRISBANE, CA
Vergleichen Sie CDNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
17.54 | 855.25M | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
412.06 | 152.18B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
196.11 | 135.78B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
518.10 | 39.54B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.77 | 30.49B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
142.82 | 25.78B | 15.50B | 1.33B | 2.16B | 7.34 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
| 2024-08-19 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-05-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Hochstufung | Craig Hallum | Hold → Buy |
| 2023-11-09 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-03-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-03-03 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2021-07-20 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-26 | Eingeleitet | BTIG Research | Buy |
| 2020-06-19 | Bestätigt | H.C. Wainwright | Buy |
| 2019-10-01 | Fortgesetzt | Craig Hallum | Buy |
| 2019-05-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Eingeleitet | Jefferies | Buy |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Neutral |
| 2017-11-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-14 | Bestätigt | Mizuho | Buy |
| 2015-09-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Eingeleitet | Craig Hallum | Buy |
| 2015-03-18 | Bestätigt | Mizuho | Buy |
Alle ansehen
Caredx Inc Aktie (CDNA) Neueste Nachrichten
ChatGPT dijo: CareDx Agrees to Pay Settlement to $CDNA Investors — Here’s How to Get Your Share - TradingView
Transplantation Market Growth, Trends & Forecast 2025 | Top key playersCareDx, Inc., Hologic, Inc, QIAGEN. - openPR.com
Major Stock Sale by CareDx Director Revealed! - TipRanks
CareDx to Participate in Upcoming Investor Conferences - Bluefield Daily Telegraph
CareDx Secures Speaking Slots at Goldman Sachs and Jefferies Healthcare Conferences - Stock Titan
CareDX, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information - ACCESS Newswire
CareDx Director Makes a Significant Stock Sale! - TipRanks
Insider Sell: Christine Cournoyer Sells 16,700 Shares of CareDx Inc (CDNA) - GuruFocus
Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position - Yahoo Finance
CareDx (CDNA) Maintains Overweight Rating and $40 Price Target | - GuruFocus
CareDx (CDNA) Maintains Overweight Rating and $40 Price Target | CDNA Stock News - GuruFocus
Analyst Expectations For CareDx's Future - Benzinga
CareDx (CDNA) Stock Rating and Price Target Update | CDNA Stock News - GuruFocus
CareDx outlines $365M-$375M 2025 revenue target while advancing transplant solutions - MSN
CDNA 7/22/22 DEADLINE: Lieff Cabraser Urges CareDx Investors to Contact Us About Pending Securities Fraud Action - ACCESS Newswire
Insider Sell: Peter Maag Sells 13,281 Shares of CareDx Inc (CDNA) - GuruFocus
Is There An Opportunity With CareDx, Inc's (NASDAQ:CDNA) 28% Undervaluation? - simplywall.st
BTIG cuts CareDx stock price target to $30, maintains Buy rating - Investing.com Australia
CareDx, Inc (NASDAQ:CDNA) Q1 2025 Earnings Call Transcript - Insider Monkey
An Intrinsic Calculation For CareDx, Inc (NASDAQ:CDNA) Suggests It's 28% Undervalued - Yahoo Finance
CareDx First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
CareDx (CDNA) Stock Sees Target Price Cut by BTIG Amid Market Vo - GuruFocus
CareDx Inc. Reports Strong Growth Amid Challenges - TipRanks
BTIG cuts CareDx stock price target to $30, maintains Buy rating By Investing.com - Investing.com South Africa
CareDx price target lowered to $30 from $35 at BTIG - TipRanks
CareDx (CDNA) Reports Strong Q1 2025 Earnings Growth - GuruFocus
CareDx: Q1 Earnings Snapshot - New Haven Register
CareDx Inc (CDNA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Investments - Yahoo Finance
CareDx Reports First Quarter 2025 Results | CDNA Stock News - GuruFocus
CareDx Q1 2025 slides: revenue up 18%, seventh consecutive quarter of volume growth By Investing.com - Investing.com South Africa
CareDx Reports Strong Q1 2025 Growth - TipRanks
CareDx Inc (CDNA) Q1 2025 Earnings: EPS Beats Estimates with Rev - GuruFocus
Earnings call transcript: CareDx beats Q1 2025 EPS expectations By Investing.com - Investing.com Canada
Caredx Inc earnings beat by $0.28, revenue topped estimates - Investing.com India
Earnings call transcript: CareDx beats Q1 2025 EPS expectations - Investing.com
CareDx (CDNA) Tops Q1 Earnings Estimates - Yahoo Finance
CareDx Q1 2025 slides: revenue up 18%, seventh consecutive quarter of volume growth - Investing.com India
CareDx (CDNA) Forecasts Strong Financial Performance for FY25 | - GuruFocus
CareDx (CDNA) Reports Strong Q1 Revenue with Growth in Kidney Su - GuruFocus
CareDx Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CareDx, Inc. SEC 10-Q Report - TradingView
Earnings Flash (CDNA) CAREDX INC. Reports Q1 Adjusted EPS $0.09 - marketscreener.com
Earnings Flash (CDNA) CAREDX INC. Reports Q1 Revenue $84.7M, vs. FactSet Est of $84.4M - marketscreener.com
CareDx Reports First Quarter 2025 Results - The Joplin Globe
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH), Repligen (RGEN) and CareDx (CDNA) - The Globe and Mail
CareDx, Inc. to Host Earnings Call - ACCESS Newswire
Finanzdaten der Caredx Inc-Aktie (CDNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Caredx Inc-Aktie (CDNA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| COURNOYER CHRISTINE | Director |
May 12 '25 |
Sale |
15.96 |
29,136 |
465,022 |
37,045 |
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):